Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Low temperature vacuum drying process for production of probiotics

Probiotic bacteria are rapidly gaining ground as healthy food supplements. However, the production of this "functional food" has its pitfalls: only few probiotic bacterial strains are robust enough to survive conventional production processes.

7 Jul 2011

Spiking Neural Network architecture aims to map out brain's individual functions

University of Manchester scientists have taken a key step towards producing a high-performance computer which aims to create working models of human brain functions.

7 Jul 2011

New technology can inexpensively render medical linens, clothing permanently germ-free

A University of Georgia researcher has invented a new technology that can inexpensively render medical linens and clothing, face masks, paper towels-and yes, even diapers, intimate apparel and athletic wear, including smelly socks-permanently germ-free.

6 Jul 2011

New technologies could bring innovative sensors, devices for 'lab-on-a-chip' applications

Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.

6 Jul 2011

Drug companies' desires to maintain status quo are 'lethal'

In the second of a two-part Al Jazeera opinion piece series "examining the methods by which multinational drug corporations inflate their expenses and justify their pricing strategies," Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, looks at U.S. tax laws, lax oversight of international clinical trials, the cost of research on new pharmaceutical compounds, and vaccine manufacturing.

6 Jul 2011

Viewpoints: Medical docs begin residency, best practices, Kansas abortions

Today, after four arduous years of examinations, graduating medical doctors will report to their residency programs. Armed with stethoscopes and scalpels, they're preparing to lead the charge against disease in its ravaging, chimerical forms. They carry with them the classic tomes: Harrison's Principles of Internal Medicine and Gray's Anatomy. But I have an unlikely addition for their mental rucksacks: "Grimm's Fairy Tales".

2 Jul 2011

Panel advises FDA to reject Avastin as breast cancer drug

The unanimous recommendation by this committee of cancer experts increases the likelihood that the drug will no longer be widely available for the treatment of breast cancer. Avastin, however, will continue to have the Food and Drug Adminstration's approval for use in treating certain other cancers.

1 Jul 2011

First Edition: June 30, 2011

Today's headlines include reports about yesterday's decision from the 6th Circuit Court of Appeals upholding the health law.

30 Jun 2011

Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial

Medicago Inc. a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive final results from a Phase II human clinical trial with its H5N1 Avian Influenza VLP vaccine candidate.

30 Jun 2011

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.

30 Jun 2011

New technology reduces stress of scheduling chemotherapy treatments

The stress of scheduling chemotherapy treatments has been substantially reduced by a new technology created and implemented by a team of researchers from the Sauder School of Business at the University of British Columbia and the BC Cancer Agency.

30 Jun 2011

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Dendreon Corporation today announced that the U.S. Food and Drug Administration approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer.

30 Jun 2011

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that it has entered into a definitive distribution and supply agreement with Vertical Pharmaceuticals, Inc., a U.S.-based specialty pharmaceutical company, under which Cipher has granted Vertical the exclusive right to market, sell and distribute CIP-TRAMADOL ER in the United States.

29 Jun 2011

Tibotec, Gilead Sciences enter license agreement for new combination product of PREZISTA and cobicistat

Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.

28 Jun 2011

Merck, UPS extend logistics and distribution agreement

UPS and Merck, known as MSD outside the United States and Canada, today announced that the companies have significantly broadened their existing distribution and logistics agreement to include aspects of Merck's global supply chain around the world.

28 Jun 2011

Cynosure announces acquisition of HOYA ConBio's aesthetic laser business

Building on its reputation as a global technology leader in laser and light-based aesthetic systems, Cynosure, Inc. today announced that it has acquired the assets of the aesthetic laser business of HOYA ConBio, a wholly owned subsidiary of Japan-based HOYA Corporation, for $24.5 million in cash. HOYA ConBio is based in Fremont, California.

28 Jun 2011

DSM introduces Kremer Method for rapid, cost effective production of biopharmaceuticals

Royal DSM, the global Life Sciences and Materials Sciences company, today announced the introduction of the Kremer Method, an innovative proprietary technology developed by DSM scientists which improves downstream processing of monoclonal antibodies (mAbs) for faster and more cost effective production of biopharmaceuticals

28 Jun 2011

Yale University: Gabapentin clinical study on epilepsy may have been a 'seeding trial'

Yale School of Medicine researchers have found that a clinical trial of the epilepsy drug gabapentin may have been a "seeding trial" used by a pharmaceutical company to promote the drug and increase prescriptions, according to a report in the June issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

28 Jun 2011

FDA approves Althea's PAI to manufacture commercial parenteral product

Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.

28 Jun 2011

Microbix renegotiates key terms of Hunan influenza vaccine joint venture

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and biological products announced today that it is renegotiating key terms of the original joint venture agreement with their Joint Venture partner Hunan Biopharmaceutical Co. Ltd.

28 Jun 2011

Manufacturing News and Research

Further Reading

Low temperature vacuum drying process for production of probiotics

Spiking Neural Network architecture aims to map out brain's individual functions

New technology can inexpensively render medical linens, clothing permanently germ-free

New technologies could bring innovative sensors, devices for 'lab-on-a-chip' applications

Drug companies' desires to maintain status quo are 'lethal'

Viewpoints: Medical docs begin residency, best practices, Kansas abortions

Panel advises FDA to reject Avastin as breast cancer drug

First Edition: June 30, 2011

Positive final results from Medicago's H5N1 Avian Influenza VLP vaccine Phase II trial

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

New technology reduces stress of scheduling chemotherapy treatments

Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility

Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER

Tibotec, Gilead Sciences enter license agreement for new combination product of PREZISTA and cobicistat

Merck, UPS extend logistics and distribution agreement

Cynosure announces acquisition of HOYA ConBio's aesthetic laser business

DSM introduces Kremer Method for rapid, cost effective production of biopharmaceuticals

Yale University: Gabapentin clinical study on epilepsy may have been a 'seeding trial'

FDA approves Althea's PAI to manufacture commercial parenteral product

Microbix renegotiates key terms of Hunan influenza vaccine joint venture

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News